| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $348.9M | +8.5% |
| Cost of Revenue | $60.1M | +10.0% |
| Gross Profit | $288.8M | +8.2% |
| R&D Expense | $12.3M | -2.6% |
| SG&A Expense | $225.1M | +6.6% |
| Operating Income | $58.9M | +58.6% |
| Pre-tax Income | $57.3M | +87.0% |
| Income Tax | $15.3M | +141.6% |
| Net Income | $42.4M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $104.4M | +27.3% |
| Accounts Receivable | $55.8M | +3.6% |
| Inventory | $23.8M | +13.3% |
| Current Assets | $191.9M | +16.8% |
| Total Assets | $263.9M | +10.4% |
| Current Liabilities | $45.6M | -0.9% |
| Long-term Debt | $19.0M | -62.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $66.2M | +147.2% |
| Investing Cash Flow | -$9.6M | -344.7% |
| Financing Cash Flow | -$34.2M | -299.1% |
| -27.2% |
| EPS (Basic) | $0.29 | -27.5% |
| EPS (Diluted) | $0.28 | -24.3% |
| Total Liabilities |
| $70.8M |
| -26.5% |
| Stockholders' Equity | $193.1M | +35.3% |